Levetiracetam impurity and synthesis method thereof
The invention discloses a novel levetiracetam impurity as shown in a formula I and a synthesis method of the novel levetiracetam impurity. The formula I is shown in the description. 本发明公开了种式I所示的左乙拉西坦新杂质以及该杂质的合成方法,
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
17.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention discloses a novel levetiracetam impurity as shown in a formula I and a synthesis method of the novel levetiracetam impurity. The formula I is shown in the description.
本发明公开了种式I所示的左乙拉西坦新杂质以及该杂质的合成方法, |
---|---|
AbstractList | The invention discloses a novel levetiracetam impurity as shown in a formula I and a synthesis method of the novel levetiracetam impurity. The formula I is shown in the description.
本发明公开了种式I所示的左乙拉西坦新杂质以及该杂质的合成方法, |
Author | ZHU KUN LIN WENQUAN ZHU YUANXUN GONG YULONG CHEN YONGBI |
Author_xml | – fullname: ZHU KUN – fullname: GONG YULONG – fullname: LIN WENQUAN – fullname: ZHU YUANXUN – fullname: CHEN YONGBI |
BookMark | eNrjYmDJy89L5WQw9kktSy3JLEpMTi1JzFXIzC0oLcosqVRIzEtRKK7MK8lILc4sVshNLcnIT1EA8opS89N4GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcQHQrLzUknhnP0MDCxMDS1NLI0djYtQAAEYsLtg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 种左乙拉西坦的杂质及其合成方法 |
ExternalDocumentID | CN108409592A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN108409592A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:45:28 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN108409592A3 |
Notes | Application Number: CN201810468738 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180817&DB=EPODOC&CC=CN&NR=108409592A |
ParticipantIDs | epo_espacenet_CN108409592A |
PublicationCentury | 2000 |
PublicationDate | 20180817 |
PublicationDateYYYYMMDD | 2018-08-17 |
PublicationDate_xml | – month: 08 year: 2018 text: 20180817 day: 17 |
PublicationDecade | 2010 |
PublicationYear | 2018 |
RelatedCompanies | ZHEJIANG HUAHAI TIANCHENG PHARMACEUTICAL CO., LTD ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD ZHEJIANG HUAHAI ZHICHENG PHARMACEUTICAL CO., LTD |
RelatedCompanies_xml | – name: ZHEJIANG HUAHAI ZHICHENG PHARMACEUTICAL CO., LTD – name: ZHEJIANG HUAHAI TIANCHENG PHARMACEUTICAL CO., LTD – name: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD |
Score | 3.2815406 |
Snippet | The invention discloses a novel levetiracetam impurity as shown in a formula I and a synthesis method of the novel levetiracetam impurity. The formula I is... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY METALLURGY ORGANIC CHEMISTRY |
Title | Levetiracetam impurity and synthesis method thereof |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180817&DB=EPODOC&locale=&CC=CN&NR=108409592A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwrSt6Jd0w8firi0ZYh2Q6bsbaRtyiqsLWtV9K_3Ejvni76FBJLLweX3u0tyB3CRJIQjquiaYzipRnpppDGWJtpVRJgV24kAZfHaIrQGT-RuYk5a8LL8CyPzhL7L5IhoUTHaey3P63IVxPLk28rqMsqwq7gJxq6nNt6xLupI2KrXd_3R0BtSlVKXhmr4iFxXeDLmde92DdYFjRZ59v3nvviVUv6GlGAHNkY4W17vQutz1oEtuqy81oHNh-bCG5uN7VV7YNzzN15nCxS3ZnMlm5ey8JzC8kSpPnIkclVWKd8VoRVB63iR7sN54I_pQMPVpz9bndJwJahxAO28yPkhKA5HZiSwl5k2Me3YYej2WQbhIjkLJ_YRdP-ep_vf4DFsC7WJKKlun0C7XrzyU4TZOjqT-vkC7v-BPg |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4gGvFNUYP4ayZmb4vCOjofiJGOZSoMYqbhjXSsizNhEDY1-td7rUN80bemTdrrJdfvvmt7B3AeRUQgqjQM27RjgzTj0OA8jozLkPDWhEYSlOVrC7_lPZK7kTUqwcvyL4zKE_qukiOiRU3Q3nN1Xs9XQSxHva3MLsIEu2bXbtB29IIdN2QdCao7nXZ3OHAGTGeszXzdf0BfVzIZ66p5swbrFCmhokpPHfkrZf4bUtxt2BjibGm-A6XP5ypU2LLyWhU2-8WFNzYL28t2weyJN5EnCxQ351Mtmc5V4TmNp5GWfaToyGVJpn1XhNakWydm8R6cud2AeQauPv7Z6pj5K0HNfSins1TUQLMFekYSe7lFiUUnNkfa1zKJkMlZBKEHUP97nvp_g6dQ8YJ-b9y79e8PYUuqUEZMG_QIyvniVRwj5ObhidLVFx6ohCg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Levetiracetam+impurity+and+synthesis+method+thereof&rft.inventor=ZHU+KUN&rft.inventor=GONG+YULONG&rft.inventor=LIN+WENQUAN&rft.inventor=ZHU+YUANXUN&rft.inventor=CHEN+YONGBI&rft.date=2018-08-17&rft.externalDBID=A&rft.externalDocID=CN108409592A |